Computational insights and impact of combinatorial peptidomimetics on immune escape SARS-CoV-2 variants
NSAA-engineered peptidomimetics act as pan-variant RBD inhibitors, resisting antigenic drift while preserving host-binding specificity. This computational-quantum hybrid strategy offers a blueprint for resilient antiviral therapeutics against evolving pathogens.
Authors
- Kapil Laddha
- Tamás A. Martinek (ORCID: https://orcid.org/0000-0003-3168-8066)
- M Elizabeth Sobhia
- Stanly Paul Matam Losery
Institutions
- University of Szeged (HU)
Publication Details
- Journal
- Expert Opinion on Drug Discovery
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1080/17460441.2026.2625825
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00